WP 2008-08 April 2008The production and profit impacts of recombinant Bovine Somatotropin (rbST) on select New York dairy farms were estimated using data over the years 1994 through 2004, by comparing matching farms which use and do not use rbST. The use of rbST increases milk production per cow and decreases the cost of production per hundredweight of milk. The cost penalty (cost reduction) is $0.39 per hundredweight for those currently using rbST to stop using rbST, while the average treatment effect is $0.73
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
Based on a 1996 United States Department of Agriculture (USDA) survey of 1,178 dairy producers and ...
Since its adoption in 1994 in the United States (U.S.), Monsanto's rBST product, Posilac, has been v...
The production and profit impacts of recombinant Bovine Somatotropin (rbST) on select New York dairy...
WP 2003-29 September 2003Production and profit impacts from the use of recombinant Bovine Somatotrop...
New York dairy farm data over the years 1994-2002 were used to estimate the impact of recombinant bo...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
WP 1998-03 April 1998Data from a panel of New York Dairy farms were used to estimate rbST adoption f...
Data from New York dairy farms for the years 1994 through 1997 were used to estimate whether recombi...
Bovine somatoropin (bST) alters total milk production and production patterns in dairy cows and unde...
whether recombinant bovine Somatotropin (rbST) generated profits for adopters. Results show that the...
Profit impact from the use of recombinant bovine somatotropin (rbST) on dairy farms was estimated us...
WP 2000-09 July 2000Data from the same 138 New York dairy farms for the years 1994 through 1997 were...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
Based on a 1996 United States Department of Agriculture (USDA) survey of 1,178 dairy producers and ...
Since its adoption in 1994 in the United States (U.S.), Monsanto's rBST product, Posilac, has been v...
The production and profit impacts of recombinant Bovine Somatotropin (rbST) on select New York dairy...
WP 2003-29 September 2003Production and profit impacts from the use of recombinant Bovine Somatotrop...
New York dairy farm data over the years 1994-2002 were used to estimate the impact of recombinant bo...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
WP 1998-03 April 1998Data from a panel of New York Dairy farms were used to estimate rbST adoption f...
Data from New York dairy farms for the years 1994 through 1997 were used to estimate whether recombi...
Bovine somatoropin (bST) alters total milk production and production patterns in dairy cows and unde...
whether recombinant bovine Somatotropin (rbST) generated profits for adopters. Results show that the...
Profit impact from the use of recombinant bovine somatotropin (rbST) on dairy farms was estimated us...
WP 2000-09 July 2000Data from the same 138 New York dairy farms for the years 1994 through 1997 were...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
Based on a 1996 United States Department of Agriculture (USDA) survey of 1,178 dairy producers and ...
Since its adoption in 1994 in the United States (U.S.), Monsanto's rBST product, Posilac, has been v...